Reactivities of the carcinogens, N-hydroxy-2-fluorenylacetamide and N-hydroxy-3-fluorenylacetamide, with tissue nucleophiles
Zieve, F.J.; Gutmann, H.R.
Cancer Research 31(4): 471-476
1971
ISSN/ISBN: 0008-5472 PMID: 5553692 Document Number: 35551
Document emailed within 1 workday
Related Documents
Weeks, C.E.; Allaben, W.T.; Louie, S.C.; Lazear, E.J.; King, C.M. 1978: Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium Cancer Research 38(3): 613-618King, C.M.; Olive, C.W. 1975: Comparative effects of strain, species, and sex on the acyltransferase- and sulfotransferase-catalyzed activations of N-hydroxy-N-2-fluorenylacetamide Cancer Research 35(4): 906-912
Scribner, J.D.; Naimy, N.K. 1973: Reactions of esters of N-hydroxy-2-acetamidophenanthrene with cellular nucleophiles and the formation of free radicals upon decomposition of N-acetoxy-N-arylacetamides Cancer Research 33(6): 1159-1164
Mellin, C.; Liu, Y.; Hacksell, U.; Björk, L.; Andén, N.E. 1987: A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT) Acta Pharmaceutica Suecica 24(4): 153-160
Xi, G.L.; Guo, X.Y.; Chen, R.L. 1980: Studies on antiasthmatic agents. II. Synthesis of some omega-(3-hydroxy-1,4-naphthoquinonyl-2)-alkanoic acids and mannich bases of 2-hydroxy-1,4-naphthoquinone Yao Xue Xue Bao 15(9): 548-554
Hullot, P.; Poudrel, J.M.; Muller, A.; Escale, R.; Rossi, J.C.; Girard, J.P.; Bonne, C. 1997: Synthesis and biochemical/pharmacological profile of the novel leukotriene B4 receptor antagonist sodium (1S*, 3S*)-1-hydroxy-3-[(3 R*S*,E)-3-hydroxy-7-phenyl-1-hepten-1-yl]-1-cyclohexane acetate Arzneimittel-Forschung 47(1): 51-58
Dupuis, L.; Brachet, P.; Puigserver, A. 1990: Oxidation of the supplemental methionine source L-2-hydroxy-4-methylthiobutanoic acid by pure L-2-hydroxy acid oxidase from chicken liver Journal of Nutrition 120(10): 1171-1178
Dooley, K.L.; Beland, F.A.; Bucci, T.J.; Kadlubar, F.F. 1984: Local carcinogenicity, rates of absorption, extent and persistence of macromolecular binding, and acute histopathological effects of N-hydroxy-1-naphthylamine and N-hydroxy-2-naphthylamine Cancer Research 44(3): 1172-1177
Satokata, I.; Asami, T.; Otsuka, T.; Sakai, K. 1986: Rapid determination of 4-hydroxy-3-methoxymandelic (vanilmandelic) acid and 4-hydroxy-3-methoxyphenylacetic (homovanillic) acid in urine by liquid chromatography with electrochemical detection Rinsho Byori. Japanese Journal of Clinical Pathology 34(7): 817-822
Levtchenko, N.K.; Osokin, D.M.; Torgov, I.V.; Arzamastzev, A.P.; Sokolova, T.M.; Tuguntaev, G.I. 1988: High-performance liquid chromatographic analysis of the by-products of the synthesis of ethynylestradiol, mestranol, 17 alpha-hydroxy-progesterone caproate and 17 alpha-hydroxy-6-dehydroprogesterone acetate Journal of Chromatography 456(2): 427-430
Pahwa, G.S.; Anand, K.K.; Johri, S.; Gupta, S.; Atal, C.K. 1987: Pharmacological and toxicological investigations of 7-hydroxy-4-phenyl-3(4-hydroxy-phenyl)-coumarin (OV1) Indian Journal of Experimental Biology 25(7): 450-453
Becker, F.F. 1975: Alteration of hepatocytes by subcarcinogenic exposure to n-2-fluorenylacetamide Cancer Research 35(7): 1734-1736
Aussel, C.; Lafaurie, M.; Castelli, D.; Formento, J.L.; Stora, C. 1982: Thyroid activity during hepatocarcinogenesis by N-2-fluorenylacetamide in the male rat Research Communications in Chemical Pathology and Pharmacology 36(1): 105-117
Maruyama, H.; Tanaka, T.; Gebhardt, R.; Berghem, L.; Williams, G.M. 1988: Decreased fibronectin in rat liver altered foci and adenomas induced by N-2-fluorenylacetamide Laboratory Investigation; a Journal of Technical Methods and Pathology 58(6): 630-635
Frith, C.H.; Littlefield, N.A.; Umholtz, R. 1981: Incidence of pulmonary metastases for various neoplasms in BALB/cStCrlfC3H/Nctr female fed N-2-fluorenylacetamide Journal of the National Cancer Institute 66(4): 703-712
Black, H.S.; Gerguis, J. 1980: Use of the Ames test in assessing the relation of dietary lipid and antioxidants to N-2-fluorenylacetamide activation Journal of Environmental Pathology and Toxicology 4(1): 131-138
Albert, R.E.; Burns, F.J.; Bilger, L.; Gardner, D.; Troll, W. 1972: Cell loss and proliferation induced by N-2-fluorenylacetamide in the rat liver in relation to hepatoma induction Cancer Research 32(10): 2172-2177
Schwartz, E.L.; Braselton, W.E.; Goodman, J.I. 1981: Factors influencing the binding of N-2-fluorenylacetamide to specific regions of the hepatic genome in vivo in rats Journal of the National Cancer Institute 66(4): 667-672
Aune, T.; Dybing, E.; Thorgeirsson, S.S. 1980: Developmental pattern of 3-methylcholanthrene-inducible mutagenic activation of N-2-fluorenylacetamide, 2-fluorenamine, and 2,4-diaminoanisole in the rabbit Journal of the National Cancer Institute 64(4): 765-769
Sidransky, H.; Verney, E. 1970: Influence of orotic acid on liver tumorigenesis in rats ingesting ethionine, N-2-fluorenylacetamide, and 3'-methyl-dimethylaminoazobenzene Journal of the National Cancer Institute 44(5): 1201-1215